Bydd nivolumab, sydd hefyd yn cael ei alw'n Opdivo®, ar gael lle bo angen clinigol amdano ddim hwyrach na 60 diwrnod ar ôl llofnodi'r cytundeb.
Nivolumab, also known as Opdivo®, will be available where clinically appropriate no later than 60 days after the agreement was signed.